" /> Olaparib - CISMeF





Preferred Label : Olaparib;

NCIt related terms : AZD2281; PARP inhibitor AZD2281;

NCIt definition : A small molecule inhibitor of the nuclear enzyme poly(ADP-ribose) polymerase (PARP) with potential chemosensitizing, radiosensitizing, and antineoplastic activities. Olaparib selectively binds to and inhibits PARP, inhibiting PARP-mediated repair of single strand DNA breaks; PARP inhibition may enhance the cytotoxicity of DNA-damaging agents and may reverse tumor cell chemoresistance and radioresistance. PARP catalyzes post-translational ADP-ribosylation of nuclear proteins and can be activated by single-stranded DNA breaks.;

Alternative definition : NCI-GLOSS: A substance being studied in the treatment of breast, ovarian, and prostate cancers caused by mutations (changes) in the BRCA1 and BRCA2 genes. It is also being studied in the treatment of other types of cancer. It blocks an enzyme involved in many functions of the cell, including the repair of DNA damage. DNA damage may be caused by normal cell actions, UV light, some anticancer drugs, and radiation used to treat cancer. AZD2281 may cause cancer cells to die. It is a type of targeted therapy agent and a type of poly (ADP-ribose) polymerase inhibitor.;

UNII : WOH1JD9AR8;

InChIKey : FDLYAMZZIXQODN-UHFFFAOYSA-N;

CAS number : 763113-22-0;

Drug name : Lynparza; Olaparix; Olanib;

Molecule name : AZD-2281; KU-0059436; AZD 2281; KU 0059436;

Chemical formula : C24H23FN4O3;

Codes from synonyms : CDR0000657862; CDR0000660871; CDR0000597093; 366;

Détails


Position du mot-clé dans l'(les) arborescence(s) : arborescence

Vous pouvez consulter :


Nous contacter.
29/07/2025


[Accueil] [Haut de page]

© CHU de Rouen. Toute utilisation partielle ou totale de ce document doit mentionner la source.